Product design and development consultancy 42 Technology (42T) is strengthening its advisory board with the appointment of Richard Archer.
Archer is founder and former ceo of The Automation Partnership (TAP) and brings more than 30 years" pharmaceutical industry experience. He will be instrumental in helping build 42T's profile and sales in the life sciences market.
"Richard's track record, international reputation and engineering skills speak for themselves and we are delighted he is joining us an advisor. His approach will be invaluable in expanding our healthcare client list and he is already actively involved in a number of our projects, particularly in regenerative medicine: a newly emerging area where human or animal cells are cultured to repair or replace damaged tissues,. said Howard Biddle, managing director of 42T.
Archer is involved in advising a number of medical technology including executive chairman of Axordia, which is commercialising breakthrough advances in stem cells from The Centre for Stem Biology.